Search by Drug Name or NDC

    NDC 00591-3659-30 Desvenlafaxine 50 mg/1 Details

    Desvenlafaxine 50 mg/1

    Desvenlafaxine is a ORAL TABLET, EXTENDED RELEASE in the HUMAN PRESCRIPTION DRUG category. It is labeled and distributed by Actavis Pharma, Inc.. The primary component is DESVENLAFAXINE SUCCINATE.

    Product Information

    NDC 00591-3659
    Product ID 0591-3659_02da0e43-e346-47ea-840f-b951aafe335c
    Associated GPIs 58180020207520
    GCN Sequence Number 063736
    GCN Sequence Number Description desvenlafaxine succinate TAB ER 24H 50 MG ORAL
    HIC3 H7C
    HIC3 Description SEROTONIN-NOREPINEPHRINE REUPTAKE-INHIB (SNRIS)
    GCN 99451
    HICL Sequence Number 035420
    HICL Sequence Number Description DESVENLAFAXINE SUCCINATE
    Brand/Generic Generic
    Proprietary Name Desvenlafaxine
    Proprietary Name Suffix n/a
    Non-Proprietary Name Desvenlafaxine
    Product Type HUMAN PRESCRIPTION DRUG
    Dosage Form TABLET, EXTENDED RELEASE
    Route ORAL
    Active Ingredient Strength 50
    Active Ingredient Units mg/1
    Substance Name DESVENLAFAXINE SUCCINATE
    Labeler Name Actavis Pharma, Inc.
    Pharmaceutical Class Cytochrome P450 2D6 Inhibitors [MoA], Norepinephrine Uptake Inhibitors [MoA], Serotonin Uptake Inhibitors [MoA], Serotonin and Norepinephrine Reuptake Inhibitor [EPC]
    DEA Schedule n/a
    Marketing Category ANDA
    Application Number ANDA204065
    Listing Certified Through 2024-12-31

    Package

    NDC 00591-3659-30 (00591365930)

    NDC Package Code 0591-3659-30
    Billing NDC 00591365930
    Package 30 TABLET, EXTENDED RELEASE in 1 BOTTLE (0591-3659-30)
    Marketing Start Date 2017-03-01
    NDC Exclude Flag N
    Pricing Information
    Price Per Unit 0.4802
    Pricing Unit EA
    Effective Date 2024-02-21
    NDC Description DESVENLAFAXINE SUCCNT ER 50 MG
    Pharmacy Type Indicator C/I
    OTC N
    Explanation Code 1
    Classification for Rate Setting G
    As of Date 2024-02-21
    This pricing file, entitled the NADAC (National Average Drug Acquisition Cost) files, provide state Medicaid agencies with covered outpatient drug prices by averaging survey invoice prices from retail community pharmacies across the United States. These pharmacies include independent retail community pharmacies and chain pharmacies. The prices are updated on a weekly and monthly basis